Herpes simplex vaccine - AuRx

Drug Profile

Herpes simplex vaccine - AuRx

Alternative Names: HSV-2

Latest Information Update: 29 Sep 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator AuRx
  • Class Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Herpes simplex virus infections

Most Recent Events

  • 29 Sep 2015 No recent reports on development identified - Phase-I/II for Herpes simplex virus infections in Mexico (Intradermal)
  • 28 Nov 2002 Follow up data from a media release have been added to the Viral Infections therapeutic trials section
  • 15 Nov 2002 A study has been added to the adverse events and Viral Infections therapeutic trials section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top